Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy
Abstract Background Diabetic retinopathy is one of the common microvascular complications of diabetes. The formation of advanced glycation end products (AGE) exerts deleterious effects by acting directly to induce cross-linking of proteins promoting vascular damage. Hyperglycemia causes disturbance...
Main Authors: | , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-04-01
|
Series: | Bulletin of the National Research Centre |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s42269-020-00304-0 |
id |
doaj-3da0384e74114cbaa68af3ae707b2fdf |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Leqaa A. Moemen Mona A. Abdel Hamid Soher Abdel Wahab Mahmoud Kenawy M. Kenawy Manal H. Abuelela Olfat A. Hassanin Marwa A. Fouly Amira A. Abdelazeem Shahira Riad Noweir Somaia M. Ismail Yara Hossam Eldin R. Abdel Gawad Safa Refaat Azza K. Amer Nervana A. Khalaf Safya H. Aboelmakarem Mehry S. Elsobky Mona R. Abdelrasool Sherif S. Karawya Zeinab M. Osman |
spellingShingle |
Leqaa A. Moemen Mona A. Abdel Hamid Soher Abdel Wahab Mahmoud Kenawy M. Kenawy Manal H. Abuelela Olfat A. Hassanin Marwa A. Fouly Amira A. Abdelazeem Shahira Riad Noweir Somaia M. Ismail Yara Hossam Eldin R. Abdel Gawad Safa Refaat Azza K. Amer Nervana A. Khalaf Safya H. Aboelmakarem Mehry S. Elsobky Mona R. Abdelrasool Sherif S. Karawya Zeinab M. Osman Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy Bulletin of the National Research Centre Advanced glycation end products Sorbitol dehyderogenas Diabetic retinopathy |
author_facet |
Leqaa A. Moemen Mona A. Abdel Hamid Soher Abdel Wahab Mahmoud Kenawy M. Kenawy Manal H. Abuelela Olfat A. Hassanin Marwa A. Fouly Amira A. Abdelazeem Shahira Riad Noweir Somaia M. Ismail Yara Hossam Eldin R. Abdel Gawad Safa Refaat Azza K. Amer Nervana A. Khalaf Safya H. Aboelmakarem Mehry S. Elsobky Mona R. Abdelrasool Sherif S. Karawya Zeinab M. Osman |
author_sort |
Leqaa A. Moemen |
title |
Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy |
title_short |
Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy |
title_full |
Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy |
title_fullStr |
Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy |
title_full_unstemmed |
Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy |
title_sort |
role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathy |
publisher |
SpringerOpen |
series |
Bulletin of the National Research Centre |
issn |
2522-8307 |
publishDate |
2020-04-01 |
description |
Abstract Background Diabetic retinopathy is one of the common microvascular complications of diabetes. The formation of advanced glycation end products (AGE) exerts deleterious effects by acting directly to induce cross-linking of proteins promoting vascular damage. Hyperglycemia causes disturbance in glycogenesis pathway resulting in reduction of glucose to sorbitol which is converted to fructose by sorbitol dehydrogenase. Methods The levels of advanced glycation end products (AGE), lipid profile, and glycosylated Hb were estimated in 266 type I diabetic patients without retinopathy, patients with nonproliferative diabetic retinopathy (NPDR), and proliferative diabetic retinopathy patients (PDR).The association between genotypes of two polymorphisms of sorbitol dehydrogenase gene (SDH) was estimated in the promoter region: a C/G transversion located at _1214 position and a G/C transversion at _888 position. This study showed allele–specific PCR for C-1214G polymorphism and restriction fragment length polymorphism (RFLP) technique for a G/C transversion at _ 888 position. Results Significant increase was detected in glycosylated Hb levels in diabetic group, both with retinopathy and without retinopathy. Also, a significant increase in Hb1c in PDR group compared to NPDR. Significant increase in total cholesterol, HDL, TG, and AGE in PDR group compared to the group without retinopathy. No significant change was observed in the same parameter between PDR and NPDR group. Significant increase in AGE in both PDR and NPDR group compared to the group without retinopathy. No significant change in PDR group compared to NPDR. The results of this study showed no significant difference in genotype distribution (C/C, C/G, G/G) of the C˗1214G polymorphism between the two groups of patients with and without DR A2-. There was no statistically significant difference between the three genotypes (CC, CG, and GG) of the C˗1214G polymorphism in relation to DR severity in male genders. However, there was a statistically significant difference in female gender with increased frequency of CC genotype (2.7%, 21.9%, and 23.7%). There was no significant difference in genotype distribution (C/C, G/C, and G/G) of the G˗888C polymorphism between the two groups of patients with DR and without DR. However, the CC genotype occurred more frequently in patients with DR than patients without DR (6.7% vs. 3.9%), and G/G genotype occurred more frequently in patients without DR than patients with DR (0.70.6 vs. 0.59.7). There was no statistically significant influence of the three genotype (GG, GC, and CC) polymorphism on DR progression in both genders. However, there was an increased frequency of CC genotypes polymorphism with severity in both genders (0.0%, 4.2%, 6.9%) in males and (5.6%, 6.3%, 8.8%) in females. Conclusion The onset of diabetic retinopathy is multifactorial, and a cascade of hyperglycemia-oxidative pathways has been involved in the initiation and progression of this disease. However, further research is required to understand the cellular and molecular mechanism of diabetic retinopathy pathogenesis. So that novel anti–diabetic retinopathy strategies can be developed, aiming to reduce the major economical and medical burden caused by diabetic retinopathy. |
topic |
Advanced glycation end products Sorbitol dehyderogenas Diabetic retinopathy |
url |
http://link.springer.com/article/10.1186/s42269-020-00304-0 |
work_keys_str_mv |
AT leqaaamoemen roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT monaaabdelhamid roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT soherabdelwahab roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT mahmoudkenawymkenawy roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT manalhabuelela roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT olfatahassanin roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT marwaafouly roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT amiraaabdelazeem roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT shahirariadnoweir roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT somaiamismail roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT yarahossameldinrabdelgawad roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT safarefaat roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT azzakamer roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT nervanaakhalaf roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT safyahaboelmakarem roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT mehryselsobky roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT monarabdelrasool roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT sherifskarawya roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy AT zeinabmosman roleofadvancedglycationendproductsandsorbitoldehydrogenaseinthepathogenesisofdiabeticretinopathy |
_version_ |
1724436855778181120 |
spelling |
doaj-3da0384e74114cbaa68af3ae707b2fdf2020-11-25T04:04:25ZengSpringerOpenBulletin of the National Research Centre2522-83072020-04-0144111110.1186/s42269-020-00304-0Role of advanced glycation end products and sorbitol dehydrogenase in the pathogenesis of diabetic retinopathyLeqaa A. Moemen0Mona A. Abdel Hamid1Soher Abdel Wahab2Mahmoud Kenawy M. Kenawy3Manal H. Abuelela4Olfat A. Hassanin5Marwa A. Fouly6Amira A. Abdelazeem7Shahira Riad Noweir8Somaia M. Ismail9Yara Hossam Eldin R. Abdel Gawad10Safa Refaat11Azza K. Amer12Nervana A. Khalaf13Safya H. Aboelmakarem14Mehry S. Elsobky15Mona R. Abdelrasool16Sherif S. Karawya17Zeinab M. Osman18Medical Biochemistry, Research institute of OphthalmologyMedical Biochemistry, Research institute of OphthalmologyMedical Biochemistry, Research institute of OphthalmologyMedical Biochemistry, Research institute of OphthalmologyPublic Health Department, Research institute of OphthalmologyMedical Retina Department, Research institute of OphthalmologyMedical Retina Department, Research institute of OphthalmologyOphthalmic Genetics, Research institute of OphthalmologyOphthalmic Genetics, Research institute of OphthalmologyNational Research CenterPublic Health Department, Research institute of OphthalmologyInternal Medicine unit, Research institute of OphthalmologyClinical and Chemical Pathology Department, Research institute of OphthalmologyClinical and Chemical Pathology Department, Research institute of OphthalmologyClinical and Chemical Pathology Department, Research institute of OphthalmologyClinical and Chemical Pathology Department, Research institute of OphthalmologyClinical and Chemical Pathology Department, Research institute of OphthalmologyMedical Retina Department, Research institute of OphthalmologyMedical Retina Department, Research institute of OphthalmologyAbstract Background Diabetic retinopathy is one of the common microvascular complications of diabetes. The formation of advanced glycation end products (AGE) exerts deleterious effects by acting directly to induce cross-linking of proteins promoting vascular damage. Hyperglycemia causes disturbance in glycogenesis pathway resulting in reduction of glucose to sorbitol which is converted to fructose by sorbitol dehydrogenase. Methods The levels of advanced glycation end products (AGE), lipid profile, and glycosylated Hb were estimated in 266 type I diabetic patients without retinopathy, patients with nonproliferative diabetic retinopathy (NPDR), and proliferative diabetic retinopathy patients (PDR).The association between genotypes of two polymorphisms of sorbitol dehydrogenase gene (SDH) was estimated in the promoter region: a C/G transversion located at _1214 position and a G/C transversion at _888 position. This study showed allele–specific PCR for C-1214G polymorphism and restriction fragment length polymorphism (RFLP) technique for a G/C transversion at _ 888 position. Results Significant increase was detected in glycosylated Hb levels in diabetic group, both with retinopathy and without retinopathy. Also, a significant increase in Hb1c in PDR group compared to NPDR. Significant increase in total cholesterol, HDL, TG, and AGE in PDR group compared to the group without retinopathy. No significant change was observed in the same parameter between PDR and NPDR group. Significant increase in AGE in both PDR and NPDR group compared to the group without retinopathy. No significant change in PDR group compared to NPDR. The results of this study showed no significant difference in genotype distribution (C/C, C/G, G/G) of the C˗1214G polymorphism between the two groups of patients with and without DR A2-. There was no statistically significant difference between the three genotypes (CC, CG, and GG) of the C˗1214G polymorphism in relation to DR severity in male genders. However, there was a statistically significant difference in female gender with increased frequency of CC genotype (2.7%, 21.9%, and 23.7%). There was no significant difference in genotype distribution (C/C, G/C, and G/G) of the G˗888C polymorphism between the two groups of patients with DR and without DR. However, the CC genotype occurred more frequently in patients with DR than patients without DR (6.7% vs. 3.9%), and G/G genotype occurred more frequently in patients without DR than patients with DR (0.70.6 vs. 0.59.7). There was no statistically significant influence of the three genotype (GG, GC, and CC) polymorphism on DR progression in both genders. However, there was an increased frequency of CC genotypes polymorphism with severity in both genders (0.0%, 4.2%, 6.9%) in males and (5.6%, 6.3%, 8.8%) in females. Conclusion The onset of diabetic retinopathy is multifactorial, and a cascade of hyperglycemia-oxidative pathways has been involved in the initiation and progression of this disease. However, further research is required to understand the cellular and molecular mechanism of diabetic retinopathy pathogenesis. So that novel anti–diabetic retinopathy strategies can be developed, aiming to reduce the major economical and medical burden caused by diabetic retinopathy.http://link.springer.com/article/10.1186/s42269-020-00304-0Advanced glycation end productsSorbitol dehyderogenasDiabetic retinopathy |